Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
59.9M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
9.28M
-
Shares change
-
+3.03M
-
Total reported value, excl. options
-
$12.7M
-
Value change
-
+$2.93M
-
Number of buys
-
15
-
Number of sells
-
-9
-
Price
-
$1.37
Significant Holders of Eledon Pharmaceuticals, Inc. - Common Stock (ELDN) as of Q2 2023
37 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock as of Q2 2023.
Eledon Pharmaceuticals, Inc. - Common Stock (ELDN) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.28M shares
of 59.9M outstanding shares and own 15.48% of the company stock.
Largest 10 shareholders include BVF INC/IL (4.33M shares), ARMISTICE CAPITAL, LLC (1.84M shares), VANGUARD GROUP INC (680K shares), Woodline Partners LP (517K shares), Ensign Peak Advisors, Inc (443K shares), Royal Bank of Canada (273K shares), CM Management, LLC (235K shares), Ikarian Capital, LLC (222K shares), GEODE CAPITAL MANAGEMENT, LLC (170K shares), and JMAC ENTERPRISES LLC (80K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.